A Brief Analysis of a New Device to Prevent Early Intubation in Hypoxemic Patients: An Observational Study

Featured Application A new device to support oxygen therapy for patients diagnosed with severe COVID-19. The need for mechanical ventilation is one of the main concerns related to the care of patients with COVID-19. The aim of this study is to evaluate the efficacy of a bubble device for oxygen supplementation. This device was implemented for the selected patients hospitalized with severe COVID-19 pneumonia with persistent low oxygen saturation. Patients were selected in three major COVID-19 hospitals of Bahia state in Brazil from July to November 2020, where they remained with the device for seven days and were monitored for different factors, such as vital signs, oximetry evaluation, and arterial blood gasometry. Among the 51 patients included in the study, 68.63% successfully overcame hypoxemia without the necessity to be transferred to mechanical ventilation, whereas 31.37% required tracheal intubation (p value < 0.05). There was no difference of note on the analysis of the clinical data, chemistry, and hematological evaluation, with the exception of the SpO(2) on follow-up days. Multivariate analysis revealed that the independent variable, male sex, SpO(2), and non-inhaled mask, was associated with the necessity of requiring early mechanical ventilation. We concluded that this bubble device should be a prior step to be utilized before indication of mechanical ventilation in patients with persistent hypoxemia of severe COVID-19 pneumonia.

Automated summary

The study evaluated the effectiveness of a bubble device for oxygen supplementation in patients with severe COVID-19, and found that directly applying this device can help most patients overcome hypoxemia and reduce the need for mechanical ventilation.